FR2751964B1 - Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique - Google Patents

Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique

Info

Publication number
FR2751964B1
FR2751964B1 FR9609742A FR9609742A FR2751964B1 FR 2751964 B1 FR2751964 B1 FR 2751964B1 FR 9609742 A FR9609742 A FR 9609742A FR 9609742 A FR9609742 A FR 9609742A FR 2751964 B1 FR2751964 B1 FR 2751964B1
Authority
FR
France
Prior art keywords
processes
preparation
therapeutic uses
novel carbocyclic
diarylmethylene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9609742A
Other languages
English (en)
Other versions
FR2751964A1 (fr
Inventor
Eric Nicolai
Michele Marie Helene Launay
Dominique Louis Potin
Jean Marie Charles Teulon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNION PHARMA SCIENT APPL
UPSA SAS
Original Assignee
UNION PHARMA SCIENT APPL
UPSA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNION PHARMA SCIENT APPL, UPSA SAS filed Critical UNION PHARMA SCIENT APPL
Priority to FR9609742A priority Critical patent/FR2751964B1/fr
Priority to US08/723,449 priority patent/US5686460A/en
Priority to JP10507673A priority patent/JP2000515161A/ja
Priority to CA002262223A priority patent/CA2262223A1/fr
Priority to PCT/FR1997/001431 priority patent/WO1998005643A1/fr
Priority to AU39443/97A priority patent/AU729453B2/en
Priority to EP97936719A priority patent/EP0915850A1/fr
Publication of FR2751964A1 publication Critical patent/FR2751964A1/fr
Application granted granted Critical
Publication of FR2751964B1 publication Critical patent/FR2751964B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
FR9609742A 1996-08-01 1996-08-01 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique Expired - Fee Related FR2751964B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9609742A FR2751964B1 (fr) 1996-08-01 1996-08-01 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique
US08/723,449 US5686460A (en) 1996-08-01 1996-10-07 Carbocyclic diarylmethylene derivatives, processes for their preparation and their uses in therapeutics
CA002262223A CA2262223A1 (fr) 1996-08-01 1997-07-31 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
PCT/FR1997/001431 WO1998005643A1 (fr) 1996-08-01 1997-07-31 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
JP10507673A JP2000515161A (ja) 1996-08-01 1997-07-31 新規の炭素環式ジアリールメチレン誘導体、その製造方法及びその治療上の使用
AU39443/97A AU729453B2 (en) 1996-08-01 1997-07-31 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
EP97936719A EP0915850A1 (fr) 1996-08-01 1997-07-31 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation et leurs utilisations en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609742A FR2751964B1 (fr) 1996-08-01 1996-08-01 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique

Publications (2)

Publication Number Publication Date
FR2751964A1 FR2751964A1 (fr) 1998-02-06
FR2751964B1 true FR2751964B1 (fr) 1998-10-30

Family

ID=9494744

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9609742A Expired - Fee Related FR2751964B1 (fr) 1996-08-01 1996-08-01 Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique

Country Status (7)

Country Link
US (1) US5686460A (fr)
EP (1) EP0915850A1 (fr)
JP (1) JP2000515161A (fr)
AU (1) AU729453B2 (fr)
CA (1) CA2262223A1 (fr)
FR (1) FR2751964B1 (fr)
WO (1) WO1998005643A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518087A (ja) * 1997-04-02 2001-10-09 メルク フロスト カナダ アンド カンパニー 選択的シクロオキシゲナーゼ−２阻害薬としてのα−メチレン−γ−ラクトン類
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
US6649645B1 (en) 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
NZ513960A (en) 1999-12-08 2004-02-27 Pharmacia Corp Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
JP2004503601A (ja) * 2000-07-13 2004-02-05 ファルマシア・コーポレーション 眼のｃｏｘ−２媒介疾患の処置及び予防におけるｃｏｘ−２阻害剤の使用法
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1363669A2 (fr) * 2001-02-02 2003-11-26 Pharmacia Corporation Methode d'utilisation d'un inhibiteur de la cyclooxygenase-2 et de steroides sexuels dans une polytherapie pour traiter et prevenir la dysmenorrhee
PE20021017A1 (es) 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
MXPA06001094A (es) * 2003-07-28 2006-04-11 Smithkline Beecham Corp Compuestos quimicos.
WO2008137740A1 (fr) * 2007-05-03 2008-11-13 Emory University Analogues de fulvène et fulvalène et leur utilisation dans le traitement des cancers
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311899A3 (fr) * 1987-10-14 1990-06-27 Air Products And Chemicals, Inc. Bis-aryldiamines alcényl alpha, bêta insaturées pour utilisation dans la préparation d'un polymère de condensation réticulant
US5344991A (en) * 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
ES2133740T3 (es) * 1994-02-10 1999-09-16 Searle & Co Espiro-compuestos sustituidos para el tratamiento de la inflamacion.
WO1995030652A1 (fr) * 1994-05-04 1995-11-16 G.D. Searle & Co. Spirodienes substitues utilises pour le traitement d'inflammations

Also Published As

Publication number Publication date
EP0915850A1 (fr) 1999-05-19
JP2000515161A (ja) 2000-11-14
AU729453B2 (en) 2001-02-01
US5686460A (en) 1997-11-11
AU3944397A (en) 1998-02-25
FR2751964A1 (fr) 1998-02-06
WO1998005643A1 (fr) 1998-02-12
CA2262223A1 (fr) 1998-02-12

Similar Documents

Publication Publication Date Title
FR2751966B1 (fr) Nouveaux derives 1,2-diarylindoles, leurs procedes de preparation, et leurs utilisations en therapeutique
DK0826673T3 (da) Acetamidderivater, fremgangsmåde til fremstilling deraf og medicinske præparater
FR2768733B1 (fr) Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques
FR2753449B1 (fr) Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2751964B1 (fr) Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2769311B1 (fr) Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
PL328608A1 (en) Novel derivatives of erythromycin, method of obtaining them and their therapeutic application as drugs
FR2731708B1 (fr) Derives de piperidine, leur procede de preparation et leur application en therapeutique
FR2747678B1 (fr) Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
FR2747124B1 (fr) Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique
FR2775477B1 (fr) Nouveaux derives diarylmethylene heterocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
FR2751647B1 (fr) Derives de benzimidazole, leurs preparations et leurs applications en therapeutique
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
NO980471L (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
FR2755439B1 (fr) Derives aryloxypropanolamines, leur procede de preparation et leurs applications
FR2754256B1 (fr) Nouveaux derives 1,2-diarylmethylenes, leurs procedes de preparation, et leurs utilisations en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2750134B1 (fr) 1-c-perfluoroalkyl glycosides, procede de preparation et utilisations
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2606015B1 (fr) Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
FR2740776B1 (fr) Polyurethannes, leur preparation et leurs utilisations
FR2743561B1 (fr) Derives de steroides, procede de preparation et utilisation en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160429